Answers are grounded in this paper and cite their sources.
Retrospective analysis shows sustained pain relief in 85% of trigeminal neuralgia patients post-MVD, indicating its effectiveness.
Background: Microvascular decompression (MVD) is a well-established surgical treatment for trigeminal neuralgia (TGN), offering significant long-term pain relief. Objective: To evaluate the long-term outcomes and recurrence rates following MVD in a cohort of 45 TGN patients at our institute. Methods: A retrospective analysis was conducted on 45 patients who underwent MVD for TGN between 2017 and 2019. Data on demographics, clinical presentation, surgical details, and follow-up outcomes were collected and analyzed. Results: Immediate postoperative pain relief was achieved in 92% of patients. At a mean follow-up of 5 years, 85% of patients remained pain-free, while 8.9% experienced partial recurrence, and 4.4% had complete recurrence. Conclusion: MVD remains a highly effective treatment for TGN, with sustained long-term pain relief in the majority of patients.
No takes yet. Share an insight, caveat, or question.
Irshad et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: